A 'Spring Forward' a farkon wannan shekarar Apple ya gabatar BincikeKit, a tsarin bude ido wanda aka tsara shi zuwa binciken likita. Tun lokacin da aka ƙaddamar da shi a hukumance, duk da haka, ResearchKit bai sami kulawa mai yawa daga masu haɓakawa ko cibiyoyin bincike na likita ba. Rahoton da ya nuna cewa manyan kamfanonin harhada magunguna guda biyu suna aiki kan haɗa ResearchKit cikin gwajin su na asibiti. Daya daga cikin kamfanonin, GlaxoSmithKline, yana daya daga cikin manyan masu kera magunguna a duniya.
Yanzu, aƙalla kamfanonin magunguna guda biyu suna la'akari da amfani da ResearchKit a cikin ƙoƙari don riba. 'GlaxoSmithKline', ɗayan manyan masu samar da magunguna a duniya, yana aiki kan haɗa ResearchKit a cikin gwaji na asibiti, kuma suna son farawa a cikin fewan watanni masu zuwa. Kamfanin ya ce tsarin bude tushen Apple hanya ce madaidaiciya zuwa inganta haɓaka haƙuri da tattara bayanai.
Gaskiya ne! Muna neman na Apple #RearchKit don gwaji na asibiti http://t.co/zZhLhXoKbf
- GSK (@GSK) Yuli 10, 2015
Wani kamfanin harhada magunguna 'Purdue Pharma', ya kuma ce Sun kasance a farkon matakan yanke hukunci ko Apple's ResearchKit ya dace da tattara bayanai daga bincikensu daga gwajin lafiyarsu ko a'a.
Mutane sun daɗe suna magana game da shi, amma ba su iya samun cikakkiyar hanyar da za ta amfani da bayanan da kuma cin amfaninta ba. ResearchKit zai zama babban mahimmin ci gaba a cikin ikon motsa wannan damar tattara bayanan.
Babban burin Apple shine don ResearchKit ya sami gagarumin tasiri ga lafiyar mutane Kuma yayin da hakan ke faruwa, kamfanin ya samarwa da kamfanonin harhada magunguna wannan tsarin don amfanin su. Kamfanin Cupertino, duk da haka, zai tsara aikace-aikacen da ke dauke da ResearchKit a cikin App Store.